ACC 2023 | RENOVATE-COMPLEX-PCI: Intravascular Imaging-Guided vs. Angiography-Guided Complex PCI

Patients with complex coronary artery disease (CAD) undergoing percutaneous coronary intervention (PCI) have worse clinical outcomes tan patients with non-complex CAD. Several studies have shown that the use of intravascular imaging (IVUS, OCT) have reduced major adverse events vs. angiography guided PCI. However, these studies present limitations both of size, studied population, short term followup and selection bias. 

Angioplastia compleja guiada por IVUS vs angiografía

The aim of this prospective, randomize, open label and multicenter study of superiority was to determine whether intravascular imaging guided PCI might improve clinical outcomes vs. angioplasty guided PCI in patients with complex CAD. 

Primary end point was target vessel failure (TVF) defined as a composite of cardiac death, target vessel MI and clinically driven target vessel revascularization. 

Researchers looked at 1639 patients randomized to intravascular imaging guided PCI N=1092) and angiography guided PCI (N=547). Mean age was 65 and patients were mostly men. 

The most frequent clinical presentation was acute coronary syndrome (ACS) (50.8%), and unstable angina was the most prevalent (32.6%). Complex coronary lesions were defined as long lesions (54.8%), multivessel lesions (37.9%), bifurcations (21.9%), chromic total occlusions (19.5%), multiple stents (18.6%), ostial lesions (15.3%), instent restenosis (14.4%), severe calcification (14.1%) and unprotected left main PCI (11.7%). IVUS was used more often (74.5%).

Read also: ACC 2023 | TAVR in Low Risk Patients: 3-Year Outcomes.

TVF in the intravascular imaging guided PCI was 7.7% vs 12.3% in the angioplasty guided PCI (HR: 0.64; 95% CI, 0.45 – 0.89; P=0.008). When comparing OCT vs IVUS guided PCI, there were no differences in TVF at one year (P=0.248).

Conclusion 

Among patient with complex CAD, the use of intravascular imaging guided PCI was associated with lower incidence of cardiac death, target vessel MI or clinically driven revascularization vs angioplasty guided PCI. The RENOVATE-COMPLEX-PCI supports the use of intravascular imaging guided PCI in the treatment of patients with complex CAD. 

Dr. Andrés Rodríguez

Dr. Andrés Rodríguez.
Member of the Editorial Board of SOLACI.org.

Original Title: Intravascular Imaging-Guided Versus Angiography-Guided Complex PCI. The RENOVATE-COMPLEX-PCI Trial.

Reference: Joo-Yong Hahn, MD, PhD et al. 


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

Coronary Artery Disease in Aortic Stenosis: CABG + SAVR vs. TAVR + PCI: Data from Spanish Centers

Multiple randomized studies have shown comparable or superior efficacy of transcatheter aortic valve replacement (TAVR) vs. coronary artery bypass graft (CABG).  However, many of...

Evolution of Small Balloon-Expandable Valves

Small aortic rings (20 mm) have posed a significant challenge for both surgery and transcatheter aortic valve implantation (TAVI) due to their association with an...

TCT 2024 | FAVOR III EUROPA

The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...

TCT 2024 – ECLIPSE: Randomized Study of Orbital Atherectomy vs Conventional PCI in Severely Calcified Lesions

Coronary calcification is associated with stent under-expansion and increased risk of both early and late adverse events. Atherectomy is an essential tool for uncrossable...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....